NP35925 Cardiovascular & Respiratory Medicines
Buyers
Value
£82,305,880
Suppliers
- Martindale Pharma
- GlaxoSmithKline
- Aventis Pharma ltd t/a Sanofi
- Selective Supplies Ltd
- Accord
- Colonis Pharma Ltd
- Pfizer Limited
- Northumbria Healthcare NHS Foundation Trust
- Dr Reddy's Laboratories (UK) Ltd
- ASPIRE
- Focus Pharmaceuticals Ltd
- Aguettant Ltd
- Day Lewis Medical Ltd
- Techdow Pharma England Ltd
- Venipharm LTD
- Chiesi Limited
- Mercury Pharmaceuticals Limited
- STADA UK - Thornton & Ross
- CST Pharma Ltd
- Glenmark Pharmaceuticals Europe Ltd
- Kent Pharmaceuticals Ltd
- Sandoz
- Wockhardt UK Limited
- Zentiva Pharma UK Ltd
- Celix Pharma Ltd.
- Hikma Pharmaceutical International Limited
- MSN Labs
- Perennial Pharma Ltd
- Viatris UK Healthcare Ltd
- Bowmed Ibisqus Limited
- Bristol Laboratories
- Consilient Health Ltd
- Galvany Pharma
- Gennisium Pharma SAS
- Grindeks Kalceks
- Hameln Pharma Ltd
- Macure Pharma ApS
- Morningside Pharmaceuticals Limited
- Ranbaxy (UK) Ltd
- Rosemont Pharmaceuticals Ltd
- Stirling Anglian Pharmaceuticals
- SyriMed
Classifications
- Pharmaceutical products
Tags
- award
- contract
Published
1 week ago
Description
This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into nineteen (19) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Organisation
+44 07483141961
+44 7891785953
+44 08000352525
Timeline complete
Complete